Skip to content

Retatrutide

Also called LY3437943 (triple agonist)

Triple GIP/GLP-1/glucagon receptor agonist.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss
3-RT by AminoWell USA
Photo: AminoWell USA

Where to get Retatrutide

AminoWell USA
Injectable
Code CAMERON

Create a free account (21+), then use code CAMERON. The only form sold. Research compound, not approved for human use.

Shop injectable at AminoWell USA

The short version

  • Why people research itSignificant fat loss via triple GLP-1/GIP/glucagon agonism.
  • What the evidence isPhase 3 has read out: TRIUMPH-4 (11 Dec 2025), TRIUMPH-1 (21 May 2026), and TRIUMPH-2 and TRIUMPH-3 (23 Jul 2026).
  • What to watchBelly pain that bores through to the back.

How Retatrutide works

Triple GIP/GLP-1/glucagon receptor agonist — appetite suppression and insulin sensitivity plus glucagon-driven energy expenditure.

Retatrutide is one molecule that has to satisfy three different receptors, and two of them pull in opposite directions. It is a single-chain peptide agonist at the GIP, GLP-1 and glucagon receptors Jastreboff 2023.

Why anyone would add a glucagon agonist on purpose. The glucagon receptor is a class B GPCR concentrated in hepatocytes. Beyond glycogenolysis and gluconeogenesis it drives hepatic fatty acid oxidation and raises resting energy expenditure.

  • Injectable

On the goal map: Hepatic fat & fatty liver (Metabolic health & insulin sensitivity)

Research on Retatrutide5 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Phase 3 human (TRIUMPH-1 to -4 reported; phase 2: 24.2% at 48 weeks).

Human clinical evidence

  • Phase 2 produced the largest weight loss recorded for any drug in a randomized trial. Phase 3 has read out: TRIUMPH-4 (11 Dec 2025), TRIUMPH-1 (21 May 2026), and TRIUMPH-2 and TRIUMPH-3 (23 Jul 2026).

  • Lilly plans to file with the FDA in Q1 2027. It isn't approved anywhere.

Correlative data

  • Widely used ahead of approval through research channels. Reported experience tracks the trial — very strong appetite suppression, and a noticeably higher rate of the heart-rate increase seen in the published data.

How the mechanism reads

  • A triple agonist: GLP-1, GIP and glucagon. The glucagon arm is the novel part and the reason for the effect size — glucagon receptor agonism raises energy expenditure rather than only reducing intake, so this attacks both sides of the balance where the dual and single agonists attack one.

    Mechanistic
  • The same glucagon activity predicts the two things to watch: raised heart rate, and effects on hepatic glucose output that make it less predictable in someone with unstable glycemic control.

    Mechanistic

Sources

  • Pasqualotto E, et al. Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers. Metabolism Open 2024 · PMID 39318607

Retatrutide safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Personal or family history of medullary thyroid cancer or MEN2: the GLP-1 arm carries the class C-cell signal.
  • Pancreatitis history or gallbladder disease: three-receptor appetite suppression speeds weight loss that provokes gallstones.
  • Type 1 diabetes or insulin or sulfonylurea use: three insulin-sensitizing arms raise hypoglycemia risk.
  • Resting tachycardia or an arrhythmia: the glucagon arm raises heart rate.
  • Pregnancy or conception plans: large energy deficits and untested triple agonism do not fit gestation.

What’s expected

  • Large appetite drop, through GIP and GLP-1 signaling plus glucagon-driven energy burn.
  • Nausea early, easing over weeks.
  • Faster resting pulse.
  • Some lean mass lost alongside fat, so protein and training matter.

Watch for

  • Belly pain that bores through to the back.
  • Right-sided pain with fever or yellow eyes while using Retatrutide.
  • Heart racing or pounding at rest.
  • Dizziness and very little urine after vomiting.

Labs that tell you it’s working

  • HbA1c (Hemoglobin A1c)
  • Lipase
  • Lipid Panel
  • Cystatin C with eGFR

Retatrutide is a triple GIP, GLP-1 and glucagon agonist; newer than semaglutide, so fewer outcome trials reflects calendar, not failure. PMID 37366315 PMID 38858523

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The “On a GLP-1 (Semaglutide / Tirzepatide)” panel, explained

Retatrutide FAQ4 common questions

Is Retatrutide approved for human use?
No. Retatrutide is a research compound.
What is Retatrutide researched for?
Significant fat loss via triple GLP-1/GIP/glucagon agonism.
Which labs show whether it's doing anything?
HbA1c; Lipase; Lipid Panel; Cystatin C with eGFR: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Retatrutide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Retatrutide is. Skool covers how it is run.

Free on this page

What Retatrutide is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Retatrutide is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The Retatrutide lesson: the protocol, step by step, with Cam's video
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool